Neurophoenix
Biotechnology - Paris, Île-de-France, France
Neurophoenix Employees
Neurophoenix Details
The objective of Neurophoenix is to develop a drug candidate for the treatment of neurodegenerative diseases. The spectacular neuroprotective and neuroregenerative properties of our molecule bring a radically new approach to those diseases as it adresses the central degeneration process and not the causes. This project stems from the academic research conducted within the viral neuro-immunology unit at Institut Pasteur. Our development strategy is to target at first the neurodegenerative diseases leading to the loss of vision like glaucoma or non-arteritic anterior ischemic optic neuropathy (NAION), a stroke of the optic nerve.Since Januray 1st, 2017, Neurophoenix is co-incubated by Agoranov and Institut de la Vision incubator.
Neurophoenix Technologies
CMS
WordPress.org
Fonts
Typekit
Tag Management
Google Tag Manager
Other
Mobile Friendly